The Centers for Medicare & Medicaid Services (CMS) issued a ground-breaking draft national coverage decision (NCD) on January 11, 2022, for Food & Drug Administration (FDA) approved monoclonal ...
CMS announced a new funding opportunity for development, improvement and expansion of quality measures for the Quality Payment Program. Over three years, the agency will provide up to $30 million in ...
On February 13-14, 2023, the Centers for Medicare & Medicaid Services (CMS) convened a virtual panel of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) to evaluate changes to ...
Update, December 12: As a technical matter, commenter Laurie Fenton Ambrose is correct that CMS did not officially propose coverage with evidence development (CED), and this post has been edited to ...
The Centers for Medicare & Medicaid Services appears to be quietly considering Palantir to support its yearslong efforts to ...
CMS’ new $50 billion rural health fund seeks to help rural providers sustain care in their communities over the next five years. However, experts believe the program will not be enough to stabilize ...